CIK 0001437402 · Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $486,197
- in 8 filings
Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- RAAB MICHAEL −$226K President & CEO sold 3% of stake
- Bishop John E −$76K See Remarks sold 6% of stake
- Brady James Parker −$58K Chief Human Resources Officer sold 6% of stake
- Williams Laura A −$41K Chief Patient Officer sold 3% of stake
- Foster Eric Duane −$33K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-26 | MOTT DAVID M Director | Option exercise | +100,000 | $0.55 | $55K | 1,738,765 |
| 2024-12-26 | MOTT DAVID M Director | Option exercise · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2024-12-19 | MOTT DAVID M Director | Purchase | +213,300 | $4.67 | $997K | 1,638,765 |
| 2024-12-10 | RAAB MICHAEL President & CEO | Option exercise 10b5-1 | +25,000 | $0.99 | $25K | 1,175,385 |
| 2024-12-10 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −25,000 | $5.26 | $132K | 1,150,385 |
| 2024-12-10 | RAAB MICHAEL President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 520,000 |
Page 11 of 11 · 206 trades